Joseph Berardo Jr., CEO of Concordia Care, Inc., a specialty risk-transfer, care-coordination company grounded in behavioral health sciences that provides “carve-outs” for catastrophic, complex and large loss cases joins eHealth Radio and the Health News Channel.
Listen to interview with host Eric Michaels & guest Joseph Berardo Jr. discuss the following:
- Give us an overview of Concordia and the types of companies and organizations it services.
- How do you describe the Pathways 2 Recovery model and the importance of its patient centric focus?
- Please explain the Concordia distinction as a “specialty risk-transfer company” and how that capability differentiates the company in the marketplace.
- Explain the casualty sector and the relevance of Concordia for injuries related to workers comp.
- With the nation’s focus on opioid abuse, Concordia’s Pathways 2 Recovery model is positioned to provide an important solution. Tell us how the combination of behavioral health and clinical approaches advance individual recovery.
Joseph Berardo, Jr. has a successful track record of building progressive companies in the healthcare services marketplace, and recruiting talented, highly motivated teams to advance corporate positioning. As CEO, he guides the strategic focus of Concordia Care, Inc. to provide risk transfer solutions and coordination of care in the casualty and behavioral health marketplaces.
Under his direction, Concordia Care is leveraging its specialized capabilities in managing the most complex behavioral health challenges to create Pathways to Recovery for acute and non-acute catastrophic cases. Berardo oversees company operations in managed behavioral health programs for commercial insurers, self-Insured companies, Medicare, Medicaid, and specialized government-sponsored programs.
Mr. Berardo also serves on the Board, and is an investor in, the Brighton Health Group as a result of Brighton’s acquisition of MagnaCare in January 2014. He served for more than eight years as CEO of MagnaCare before transitioning to Non-Executive Chairman in January 2016. Berardo began his tenure at MagnaCare as Vice President of Sales and Marketing in January of 2003, He took over as President in June 2005 and added the role of CEO in September 2007. During his time at MagnaCare, he is credited with pioneering the movement to self-insurance for worker’s compensation and health benefits, guiding employers from conventional, fully-insured to self-funded health plans, as well as boosting employer and plan sponsor initiatives to offer customer-centric plan designs which better manage healthcare costs.
His distinguished career in healthcare services began in 1990 at U.S. Healthcare, and includes subsequent leadership positions at Mount Sinai Health System, Empire Blue Cross/Blue Shield and Multiplan. Berardo has been named to the Crain’s NY Business “40 under 40,” and NJ Biz Power 50 in Health Care. Recognized as an industry thought leader, Berardo has authored numerous articles in trade and peer-reviewed publications.
Mr. Berardo is former Chairman of the Board of Directors of the Make-A-Wish foundation of NJ and former Chairman of the Board of the Ocean Medical Center Foundation. He holds a BA in Economics from Rutgers University.
Concordia Care, Inc. (Concordia) is a specialty risk transfer, care-coordination company servicing insurers, government entities, self-insured plan sponsors and other managed care organizations. Through its Pathways 2 Recovery care model, Concordia aims to improve patient-centered outcomes and reduce overall cost of quality care by applying best practices in a biopsychosocial-centric approach to manage complex challenges for the group health, casualty and auto markets. Concordia’s integrated business units include: Concordia Behavioral Health, Concordia Group Health, Concordia Casualty and Concordia Ancillary. Concordia holds dual accreditations from the Accreditation Association for Ambulatory Healthcare Inc. (AAAHC) and the National Committee for Quality Assurance (NCQA).